Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6909
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Mitsubishi Tanabe Pharma Corporation – Strategy, SWOT and Corporate Finance Report
Summary

Mitsubishi Tanabe Pharma Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe or ‘the company’), a subsidiary of Mitsubishi Chemical Holdings Corp manufactures and sells ethical pharmaceuticals. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also manufactures products for various infectious diseases. Mitsubishi Tanabe’s offers its products under brands such as Maintate, Tenelia, Remicade Simponi, Radicut, Ceredist, Lexapro, Nanpao, Talion, Flucort F, and Tetrabik. The company markets its products to wholesalers, hospitals, clinics, and drugstores. The company operates research centers in Saitama, Kanagawa and Osaka. The company has operations across Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Scope

- Detailed information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Mitsubishi Tanabe Pharma Corporation including a breakdown and examination of key business segments
- Intelligence on Mitsubishi Tanabe Pharma Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mitsubishi Tanabe Pharma Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mitsubishi Tanabe Pharma Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Mitsubishi Tanabe Pharma Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Mitsubishi Tanabe Pharma Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Mitsubishi Tanabe Pharma Corporation: Company Overview 9
Mitsubishi Tanabe Pharma Corporation: Overview and Key Facts 9
Mitsubishi Tanabe Pharma Corporation: Overview 9
Mitsubishi Tanabe Pharma Corporation: Key Facts 9
Mitsubishi Tanabe Pharma Corporation: Key Employees 11
Mitsubishi Tanabe Pharma Corporation: Key Employee Biographies 13
Mitsubishi Tanabe Pharma Corporation: Major Products and Services 16
Mitsubishi Tanabe Pharma Corporation: Company History 17
Mitsubishi Tanabe Pharma Corporation: Management Statement 23
Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries 30
Mitsubishi Tanabe Pharma Corporation: Key Competitors 31
Mitsubishi Tanabe Pharma Corporation: Company Analysis 32
Mitsubishi Tanabe Pharma Corporation: Business Description 32
Mitsubishi Tanabe Pharma Corporation: SWOT Analysis 33
Mitsubishi Tanabe Pharma Corporation: SWOT Overview 33
Mitsubishi Tanabe Pharma Corporation: Strengths 33
Mitsubishi Tanabe Pharma Corporation: Weaknesses 33
Mitsubishi Tanabe Pharma Corporation: Opportunities 34
Mitsubishi Tanabe Pharma Corporation: Threats 34
Mitsubishi Tanabe Pharma Corporation: Corporate Financial Deals Activity 36
Mitsubishi Tanabe Pharma Corporation: Financial Deals Overview 36
Mitsubishi Tanabe Pharma Corporation: Targets and Partners 38
Mitsubishi Tanabe Pharma Corporation: Top Deals 2014 – 2018YTD* 39
Mitsubishi Tanabe Pharma Corporation: Mergers and Acquisitions 40
Mitsubishi Tanabe Pharma Corporation: Partnership 41
Mitsubishi Tanabe Pharma Corporation: Divestments 42
Mitsubishi Tanabe Pharma Corporation: Recent Developments 43
Mitsubishi Tanabe Pharma Corporation: News and Events Summary 43
Mitsubishi Tanabe Pharma Corporation: Business Expansion 47
Mitsubishi Tanabe Pharma Corporation: Contracts 48
Mitsubishi Tanabe Pharma Corporation: Corporate Governance 48
Mitsubishi Tanabe Pharma Corporation: Financial Performance 49
Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events 50
Mitsubishi Tanabe Pharma Corporation: Research & Development 51
Mitsubishi Tanabe Pharma Corporation: Strategy and Operations 51
Appendix 53
Contact Us 53
Methodology 53
About MarketLine 54

List of Tables
Table 1: Mitsubishi Tanabe Pharma Corporation: Key Facts
Table 2: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 3: Mitsubishi Tanabe Pharma Corporation: Company History
Table 4: Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries
Table 5: Mitsubishi Tanabe Pharma Corporation: Key Competitors
Table 6: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (TTM*)
Table 8: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Mitsubishi Tanabe Pharma Corporation: M&A Average Deal Size - Value (US$m)
Table 10: Mitsubishi Tanabe Pharma Corporation: Targets and Partners
Table 11: Mitsubishi Tanabe Pharma Corporation: Top Deals 2014 - 2018YTD*
Table 12: Mitsubishi Tanabe Pharma Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2014 - YTD*2018)
Table 18: Mitsubishi Tanabe Pharma Corporation: News and Events Summary
Table 19: Mitsubishi Tanabe Pharma Corporation: Business Expansion
Table 20: Mitsubishi Tanabe Pharma Corporation: Contracts
Table 21: Mitsubishi Tanabe Pharma Corporation: Corporate Governance
Table 22: Mitsubishi Tanabe Pharma Corporation: Financial Performance
Table 23: Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events
Table 24: Mitsubishi Tanabe Pharma Corporation: Research & Development
Table 25: Mitsubishi Tanabe Pharma Corporation: Strategy and Operations

List of Figures
Figure 1: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (TTM*)
Figure 3: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Mitsubishi Tanabe Pharma Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: Mitsubishi Tanabe Pharma Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Mitsubishi Tanabe Pharma Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 9: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 10: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cleveland-Cliffs Inc:企業の戦略・SWOT・財務情報
    Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report Summary Cleveland-Cliffs Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Localiza Rent A Car SA:企業の戦略・SWOT・財務情報
    Localiza Rent A Car SA - Strategy, SWOT and Corporate Finance Report Summary Localiza Rent A Car SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Calian Group Ltd (CGY):企業の財務・戦略的SWOT分析
    Summary Calian Group Ltd (CTL), formerly Calian Technologies Ltd, is a diversified company that offers professional services in the areas of health, training, information technology, engineering and manufacturing. The company’s health division offers occupational health and other clinical services s …
  • Enbridge Energy Partners LP (EEP)-エネルギー分野:企業M&A・提携分析
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Presidio Pharmaceuticals Inc (Presidio Pharmaceuticals) is a clinical-stage pharmaceutical company that discovers, develops, and supplies small-molecule antiviral therapeutics. The company’s products include HCV NS5A, protease inhibitor, ravidasvir hydrochloride, NS5B proteins, lead pan-geno …
  • Marvell Technology Group Ltd.:企業の戦略・SWOT・財務情報
    Marvell Technology Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Marvell Technology Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • Unico Sigorta A.S:企業の戦略・SWOT・財務分析
    Unico Sigorta A.S - Strategy, SWOT and Corporate Finance Report Summary Unico Sigorta A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Episurf Medical AB (EPIS B):企業の製品パイプライン分析
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. It offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer …
  • Consolidated Edison, Inc.:企業の戦略・SWOT・財務分析
    Consolidated Edison, Inc. - Strategy, SWOT and Corporate Finance Report Summary Consolidated Edison, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Athersys Inc (ATHX):製薬・医療:M&Aディール及び事業提携情報
    Summary Athersys Inc (Athersys) is a biotechnology company that discovers and develops of novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as ca …
  • Statkraft AS:電力:M&Aディール及び事業提携情報
    Summary Statkraft AS (Statkraft), a subsidiary of Statkraft SF, is a power utility which produces electricity and supplies district heating. It generates power from hydro, wind, gas, solar and bio-power sources. The company develops hydroelectric power plants in emerging markets outside Europe. Stat …
  • Eurofins Scientific SE:企業の戦略・SWOT・財務情報
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Huttig Building Products Inc:企業の戦略・SWOT・財務情報
    Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report Summary Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Paychex, Inc. (PAYX):企業の財務・戦略的SWOT分析
    Paychex, Inc. (PAYX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Spark Infrastructure Group:企業の発電所・SWOT分析2018
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Trivitron Healthcare Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Trivitron Healthcare Pvt Ltd (Trivitron) is a medical technology company that provides solutions to healthcare providers. The company’s products include radiography and c-arm systems, newborn screening, mammography, ultrasound, contrast media, breast biopsy system, bone densitometer, radiati …
  • Konsortium Transnasional Berhad:企業の戦略・SWOT・財務情報
    Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Konsortium Transnasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Tokyu Land Corporation:企業の戦略・SWOT・財務情報
    Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report Summary Tokyu Land Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Orix Corporation
    Orix Corporation - Strategy, SWOT and Corporate Finance Report Summary Orix Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆